THJ-2201 is an indazole-based synthetic cannabinoid that presumably acts as a potent agonist of the CB receptor and has been sold online as a designer drug.
However, it is a structural analog of AM-2201 in which the central indole ring has been replaced by indazole. Thus, it is a perfect analog of AM-2201
Cannabinoids are commonly